Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review

about

Does ALK-rearrangement predict favorable response to the therapy of bevacizumab plus pemetrexed in advanced non-small-cell lung cancer? Case report and literature review.Best Practices in Treatment Selection for Patients With Advanced NSCLC.

P2860

Q47556226-29417DCB-FCC2-41D6-A747-B4C8EF35E216 Q52814108-169CB947-9C08-4B06-8A4E-EC9C6C533AE7

P2860

Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review

Item

http://www.wikidata.org/entity/Q38935803

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Efficacy of cisplatin/pemetrex ...... e report and literature review

@en

type

Item

label

Efficacy of cisplatin/pemetrex ...... e report and literature review

@en

prefLabel

Efficacy of cisplatin/pemetrex ...... e report and literature review

@en

P1476

Efficacy of cisplatin/pemetrex ...... e report and literature review

@en

P2093

Haiyong Wang

http://www.w3.org/2001/XMLSchema#string

Hui Zhu

http://www.w3.org/2001/XMLSchema#string

Jinming Yu

http://www.w3.org/2001/XMLSchema#string

Li Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Tumorigenesis and the angiogenic switch

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer.

FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.

A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.

Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.

P304

4639-4644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S101241

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27555784

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

bevacizumab

P932

4968850

http://www.w3.org/2001/XMLSchema#string

Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review

about

P2860

P2860

Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932